Get the latest Science News and Discoveries

Quarter-million genomes analyzed in NIH project could be ‘hugely important’ for identifying disease risks

None

Get the Android app

Or read this on Science Magazine

Related news:

New toolbox allows engineering of genomes without CRISPR

Monica Bertagnolli, NIH’s New Leader, Wants to Broaden Participation in Medical Research

Omalizumab, a recombinant humanized IgG1 monoclonal antibody, reduces allergic reactions to multiple foods in NIH trial. This could expand the amount of different common foods that children with food allergies can safely consume without eliciting an allergic reaction.

« ‘As with a poem, each patient is unique’: the cancer surgeon using poetry to help train doctors

Gravastars are an Alternative Theory to Black Holes. Here's What They'd Look Like »